期刊文献+

中国六个市2007~2009年过敏性紫癜住院病例发病情况分析 被引量:31

Study on the Incidence of Hospitalized Henoch-Schnlein Purpura Cases in 6 Cities in China,2007-2009
原文传递
导出
摘要 目的分析中国六个市过敏性紫癜(Henoch-schnlein Purpura,HSP)的发生率及流行病学特征,为开展预防接种的安全性评价提供参考依据。方法采用分层多阶段整群抽样的方法,选择江西省南昌、宜春、景德镇市,云南省昆明、曲靖市,辽宁省大连市等六个设区的市,收集所有县级及以上医院2007~2009年HSP住院病例的基本信息,采用描述性方法对HSP等有关信息进行流行病学分析。结果 2007~2009年,三省六个市的县级及以上医院HSP住院病例共7743例,年平均发病率为8.82/10万;<15岁儿童5677例,年平均发病率为33.86/10万;其中有感染等明确前驱危险因素的1639例(占28.87%)。江西、云南、辽宁三省的HSP年平均发病率分别为4.08/10万、15.27/10万、6.28/10万;<15岁儿童年平均发病率分别为14.48/10万、59.42/10万、24.59/10万。云南省两个市HSP呈现春季高发的特点,江西、辽宁省四个市HSP均呈现秋冬季高发的特点。三省六个市5~9岁儿童HSP发病率均最高。结论 2007~2009年,三省六个市全人群及<15岁儿童HSP住院病例发病率较平稳,但不同地区发病率差别较大,且呈现不同的季节性高发特点,提示选择开展群体性预防接种活动的时机应考虑HSP季节性因素;接种前应仔细询问受种者有无感染史、过敏史等危险因素,以减少偶合HSP的发生。 Objective To analyze the incidence and epidemiological characteristics of Henoch-Schonlein Purpura(HSP)in selected districts in China, and to assess safety of vaccination. Methods The basic information on hospitalized HSP cases occurred in 2007-2009 were collected from hospitals at county level in 6 cities from Yunnan, Jiangxi , and Liaoning provinces, by multi-stage stratified cluster sampling method. The descriptive methodology is used for this study. Results During 2007-2009, 7743 hospitalized HSP cases occurred with an average incidence rate of 8.82 per 100, 000 people. Among them, 5677 children were 〈 15 years old, incidence rate was 33.86 per 100000, and 1639 (28.87%) with a definitely risk factors before onset. In 6 cities, average incidence rates among 3 years old children were 4.08, 6.28, 15.28 per 100, 000 people respectively, and 14.48, 24.59, 59.42 per 100,000 in children aged 〈15 years. Incidence pick was in spring in 2 cities of Yunnan, and in autum and winter in 4 cities in Jiangxi and Liaoning provinces. The incidence in group of aged 5-9 years were the highest in the investigated areas in 3 provinces. Conclusions During 2007-2009, the incidence rates of hospitalized HSP were relatively stable for whole population and 〈 15 years old children in the investigated areas in 3 provinces. However, there were apparently differences in incidence and seasonal characteristic from different provinces. These findings suggested that the time for mass campaign vaccination should be conducted according the local seasonal characteristic of HSP. Before vaccination, all recipients or their guardians should be asked carefully by vaccination providers to avoid risk factors, such as infection and allergy history.
出处 《中国疫苗和免疫》 CAS 2011年第2期128-132,共5页 Chinese Journal of Vaccines and Immunization
关键词 过敏性紫癜 发病率 Henoch-Schonlein Purpura Incidence
  • 相关文献

参考文献12

  • 1胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 2王业军,张秋业.过敏性紫癜研究进展[J].齐鲁医学杂志,2005,20(5):457-458. 被引量:18
  • 3Murat Anll, Nejat Aksu, Orhan Deniz Kara. Henoch-Schonlein purpura in children from western Turkey:a retrospective analysis of 430 cases [J]. The Turkish Journal of Pediatrics, 2009,51 (5) : 429-436.
  • 4Dolezalova P, Tdekesova P, Nemcova D. Incidence of vasculitis in children in the czech republic: 2-year prospective epidemiology survey[J].J Rheumatol, 2004, 31 (11 ): 2295-2299.
  • 5JMM Gardner-Medwin,Pavla Dolezalova, Carole Cummins, et al. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins [J ]. Lancet, 2002, 360(9341 ) : 1197-1202.
  • 6Saulsbury FT. Henoch Schonlein purpura[J]. Pediat r Dermatol, 1984, 1 ( 1 ) : 195-201.
  • 7Stewart M, Savage JM, Bell B, et al. Long term renal prognosis of Henoch-Schlein purpura in unselected childhood population[J]. EurJ Pediatr, 1988, 147(2): 113-115.
  • 8王进,刘青恋,杨超美,马千里,漆琪,关旭静,郑红茹,李健.四川省2007~2008年麻疹减毒活疫苗强化免疫活动预防接种异常反应分析[J].中国疫苗和免疫,2009,15(3):219-222. 被引量:21
  • 9何寒青,李倩,符剑,赵艳荣,陈恩富.浙江省2008年麻疹强化免疫异常反应研究[J].浙江预防医学,2009,21(10):25-27. 被引量:30
  • 10Hess RP, Bentsi-Enchill AD, Duclos P. Monitoring Vaccine Safety during Measles Mass Immunization Campaigns: Clinical and Programmatic Issues [J ]. TheJournal of Infectious Diseases, 2003, 187 (Suppl 1 ): S291-298.

二级参考文献42

  • 1梁雁,张海燕,鲁云兰,崔一民.流感疫苗安全性的调查[J].药物不良反应杂志,2005,7(2):95-97. 被引量:19
  • 2左树岩.开展麻疹疫苗强化免疫发生的预防接种不良反应[J].中国计划免疫,2005,11(6):510-511. 被引量:6
  • 3张红,李飒,董捷.麻疹强化免疫中异常反应诱发因素的分析[J].中国自然医学杂志,2006,8(1):37-39. 被引量:7
  • 4吴希如 李万镇.临床儿科学[M].北京:科学出版社,2005.1639-1640.
  • 5卫生部.预防接种异常反应鉴定办法[S].2008.
  • 6中国疾病预防控制中心.麻疹疫苗强化免疫活动指南[S].2006.
  • 7WHO.Supplementary information on vaccine safety.Part 2:Background rates of adverse events following immunization[M].Geneva:WH0/V& B/00,2000:61-64.
  • 8Araki D, Bruno J, Salama P, Sadeed A, et al. Adverse events following immunization attributable to measles vaccine are rare [J]. Disasters, 2006, 30 (2): 270-272.
  • 9Kennedy RC, Byers VS, Marchalonis JJ. Measles virus infection and vaccination: potential role in chronic illness and associated adverse events [J]. Crit Rev Immunol, 2004, 24 (2) : 129 - 56.
  • 10Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines[J]. Lancet, 2009, 374(9707):2115-22.

共引文献1272

同被引文献362

引证文献31

二级引证文献512

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部